At ASKA Pharmaceutical Holdings, we believe it is important to maintain communication with investors
and other stakeholders as we work to resolve social issues in line with our corporate philosophy of
“Contribute toward the improvement of people’s health and progress in society through the development of
innovative products.” We seek to create value over the long term as we increase profitability through
sound business practices that earn the trust of our stakeholders.
Stakeholder Outcome Impact
Stakeholders
Medical Professionals
Outcomes generated
Providing women with choices supporting healthy and fulfilled lives
Addressing unmet medical needs
Contributing to preventive medicine and improving presymptomatic states
Response/initiatives
Providing a wide variety of pharmaceuticals catering to women’s different life stages
Ensuring that pharmaceuticals are manufactured correctly and providing information on
their proper use, in doing so contributing to medical care
Using strengths in highly sensitive measurement technology for endogenous hormones to
develop healthcare business
Dialogue engagement in FY2023
Lectures for medical professionals: 63 times; total of 36,407 participants (including
online participants)
Stakeholders
Veterinary Medical Professionals and Livestock
Producers
Outcomes generated
Contributing to creation of a society in which people and animals can coexist by
protecting animal health and food safety
Response/initiatives
Enhancing the productivity of livestock operations and fisheries by utilizing our hormone
preparations for breeding and amino acids
Supplying veterinary pharmaceuticals and other products that help to maintain the health
of companion animals such as dogs and cats
Utilizing international exhibitions and online seminars to disseminate information
Dialogue engagement in FY2023
Seminars for veterinary medical professionals and livestock producers: 1 time; total of
350 participants
*
Also held several smaller seminars around Japan
Stakeholders
Local Community
Outcomes generated
Disseminating information necessary for staying healthy and confronting illness
Helping to improve women’s quality of life and promote women’s advancement
Helping to build a recycling-oriented society, preserving biodiversity, and tackling
climate change
Response/initiatives
Conducting various activities via “Health Lab Mint+ for Women’s health” website
to ensure that women have accurate information about their bodies and health
Protecting the environment, preserving biodiversity, and continuously reducing environmental
impact in all of our business activities by working to reduce energy consumption, promote
waste reduction and reuse, and control emissions of air and water pollution, chemical
substances, and other pollutants.
Dialogue engagement in FY2023
Seminars for general public (patients): 7 times; total of 743 participants
Participation in “Iwaki Carbon Neutral Human Resource Development Consortium” (Iwaki
Factory) Symposiums: 1 Lectures: 15
Stakeholders
Shareholders and Investors
Outcomes generated
Contributing to sustainable improvement in corporate value
Response/initiatives
Steadily executing Medium-Term Management Plan 2025
Maximizing our economic value while also increasing our social value by placing
sustainability at the center of our management
Taking the steps below to swiftly achieve a PBR (price-to-book ratio) of above 1x
Growth strategy (implementation of growth strategy, optimal cash allocation)
Strengthen shareholder returns (dividend payout benchmark ratio of 30% from FY2024)
Strengthen IR activities (creation of dialogue opportunities, expansion of information
disclosure)
Dialogue engagement in FY2023
Financial results presentations: 2 times; total of 90 participants
Conferences and meetings held by securities firms: 3 times
IR events for individual investors: 2 times; total of 1,286 participants
IR events for institutional investors (pipeline briefings): 1 time; total of 31
participants
One-on-one IR interviews/SR dialogue: 100 times; total of 110 companies and 163 persons
participating
Stakeholders
Employees
Outcomes generated
Realizing wellbeing
Working to enhance employee engagement
Response/initiatives
Providing regular opportunities for dialogue between employees and management
Creating a human resources system empowering all employees to maximize their individual
abilities while also putting in place training programs that respond to individuals’ desire
for autonomous learning, and to support their growth
Promoting safety and health activities at each business site in accordance with the
Company-wide Basic Policy on Safety and Health
Managing the health of our employees as well as their physical and mental well-being,
their autonomous growth, and the further enhancement of organizational productivity and
creativity
Engaging in initiatives contributing to the advancement of women as a step toward strongly
promoting diversity based on respect for diverse values
Dialogue engagement in FY2023
Dialogues between employees and top management Number of dialogues: 74 Time (hours):
110.5
Town hall meetings Number of meetings: 12 Time (hours): 12
Round table meetings Number of meetings: 23 Time (hours): 23
Workplace exchanges of opinion with labor union Number of exchanges: 1 Time (hours):
3
Informal gatherings of labor and management Number of exchanges: 2 Time (hours): 9
Stakeholder Dialogue
Stakeholder
Communication
Medical Professionals
Responding to Inquiries at the Drug Information Unit
Communication with medical professionals
Collection and provision of pharmaceutical information by Medical Representatives